Find Paid Clinical Trials in Arkansas

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Arkansas

Top of Directory » All Locations » United States » Arkansas




  • Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients

    Condition:   Presbyopia
    Interventions:   Device: Etafilcon A Multifocal Contact Lens;   Device: Etafilcon A Contact Lens
    Sponsors:   Vistakon;   Visioncare Research Ltd.
    Recruiting - verified November 2009

  • The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia

    Condition:   Chronic Myelomonocytic Leukemia
    Intervention:  
    Sponsor:   University of Arkansas
    Recruiting - verified November 2009

  • Efficacy and Safety of Budesonide Foam for Patients With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

    Conditions:   Proctitis;   Proctosigmoiditis
    Interventions:   Drug: Budesonide;   Drug: Placebo
    Sponsor:   Salix Pharmaceuticals
    Not yet recruiting - verified November 2009

  • The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Acetaminophen Biomarkers

    Condition:   Acetaminophen Toxicity
    Intervention:  
    Sponsors:   Arkansas Children's Hospital Research Institute;   National Institutes of Health (NIH)
    Recruiting - verified October 2009

  • Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

    Conditions:   Haemophilus Influenzae Type B Related Disease;   Pneumonia;   Meningitis;   Cellulitis;   Osteomyelitis;   Epiglottis
    Interventions:   Biological: GSK Biologicals' Haemophilus inluenzae type b vaccine (GSK 208108);   Biological: ActHIBTM;   Biological: PentacelTM;   Biological: PediarixTM;   Biological: PrevnarTM;   Biological: RotarixTM;   Biological: EngerixTM-B;   Biological: InfanrixTM
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009

  • Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

    Condition:   Lymphoma
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

    Conditions:   Lymphoma;   Lymphoproliferative Disorder
    Interventions:   Other: biologic sample preservation procedure;   Other: informational intervention
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

    Conditions:   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Interventions:   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI);   Eastern Cooperative Oncology Group
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

    Condition:   Pregnancy Prevention
    Intervention:   Drug: DR-103
    Sponsor:   Teva Women's Health
    Recruiting - verified October 2009

  • TAXUS Libertē Post Approval Study

    Condition:   Coronary Artery Disease
    Interventions:   Device: TAXUS Liberté Paclitaxel-Eluting Coronary Stent;   Drug: prasugrel;   Drug: placebo;   Drug: aspirin
    Sponsors:   Boston Scientific Corporation;   Eli Lilly and Company;   Daiichi Sankyo Inc.
    Not yet recruiting - verified November 2009

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Diabetic Painful Neuropathy

    Conditions:   Pain;   Diabetic Neuropathy, Painful
    Interventions:   Drug: JNJ-42160443;   Drug: Placebo
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds

    Condition:   Human Papillomavirus Infection
    Interventions:   Biological: V503;   Biological: Comparator: Menactra™ (Concomitant);   Biological: Comparator: Adacel™ (concomitant);   Biological: Comparator: Menactra™ (Non-Concomitant);   Biological: Comparator: Adacel™ (Non-concomitant)
    Sponsor:   Merck
    Recruiting - verified November 2009

  • Dapagliflozin DPPIV Inhibitor add-on Study

    Condition:   Type 2 Diabetes
    Interventions:   Drug: Dapagliflozin;   Drug: Placebo
    Sponsors:   AstraZeneca;   Bristol-Myers Squibb
    Recruiting - verified November 2009

  • Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children

    Condition:   Influenza Infection
    Interventions:   Biological: GSK investigational vaccine GSK1557482A;   Biological: Fluzone®
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age

    Condition:   Influenza Infection
    Interventions:   Biological: GSK2340273A;   Biological: GSK2340274A
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).

    Condition:   Parkinson's Disease
    Interventions:   Drug: IPX066;   Drug: regular carbidopa-levodopa
    Sponsor:   IMPAX Laboratories, Inc.
    Recruiting - verified November 2009

  • Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

    Condition:   Severe Nodular Acne
    Intervention:   Drug: CIP-Isotretinoin and Isotretinoin
    Sponsor:   Cipher Pharmaceuticals Inc.
    Recruiting - verified November 2009

  • A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain

    Conditions:   Low Back Pain;   Low Back Pain, Recurrent
    Interventions:   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: Placebo
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: JNJ-28431754;   Drug: glimepiride
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • Changing Thought and Action in Tobacco Dependence With Transcranial Magnetic Stimulation

    Condition:   Tobacco Dependence
    Interventions:   Device: repetitive transcranial magnetic stimulation (rTMS) 10Hz;   Device: repetitive transcranial magnetic stimulation (rTMS) 20Hz;   Device: SHAM repetitive transcranial magnetic stimulation (rTMS)
    Sponsor:   University of Arkansas
    Recruiting - verified November 2009

  • A Study of the Antiviral Activity, Safety, and Tolerability of Intravenous Peramivir in Adult and Adolescent Hospitalized Subjects With Confirmed or Suspected Influenza Infection

    Conditions:   Seasonal Influenza;   Cough;   Sore Throat;   Nasal Congestion;   Myalgia;   Headache;   Feverishness;   Fatigue
    Interventions:   Drug: Peramivir;   Drug: Peramivir
    Sponsors:   BioCryst Pharmaceuticals;   Department of Health and Human Services
    Recruiting - verified November 2009

  • CYPRESS - CYPheR for Evaluating Sustained Safety

    Condition:   Coronary Artery Disease
    Interventions:   Drug: Clopidogrel & Aspirin, Prasugrel & Aspirin;   Drug: Placebo & Aspirin
    Sponsor:   Cordis Corporation
    Recruiting - verified November 2009

  • Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors

    Condition:   Haemophilia A or B With Inhibitors
    Interventions:   Drug: activated recombinant human factor VII, long acting;   Drug: activated recombinant human factor VII, long acting;   Drug: activated recombinant human factor VII, long acting
    Sponsor:   Novo Nordisk
    Recruiting - verified November 2009

  • Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

    Condition:   Lung Cancer
    Interventions:   Biological: bevacizumab;   Biological: cetuximab;   Drug: carboplatin;   Drug: paclitaxel
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery

    Condition:   Aged
    Interventions:   Other: Experimental Nutritional Powder Formula;   Other: Placebo comparator
    Sponsor:   Abbott Nutrition
    Recruiting - verified November 2009

  • Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

    Condition:   Asthma
    Interventions:   Drug: QMF149 Twisthaler®;   Drug: Mometasone Twisthaler®
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified November 2009

  • An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Intervention:   Drug: Dimebon
    Sponsors:   Pfizer;   Medivation, Inc.
    Recruiting - verified November 2009

  • Dinaciclib in Treating Patients With Stage IV Melanoma

    Condition:   Melanoma (Skin)
    Intervention:   Drug: dinaciclib
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer

    Condition:   Breast Cancer
    Interventions:   Drug: gemcitabine/carboplatin;   Drug: gemcitabine/carboplatin plus BSI-201
    Sponsor:   BiPar Sciences
    Recruiting - verified November 2009

  • 28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

    Condition:   Schizophrenia
    Interventions:   Drug: paliperidone palmitate;   Drug: oral risperidone
    Sponsor:   Ortho-McNeil Janssen Scientific Affairs, LLC
    Recruiting - verified November 2009

  • Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

    Condition:   Bronchiectasis
    Interventions:   Drug: Cipro (Ciprofloxacin, BAYQ3939);   Drug: Placebo
    Sponsors:   Bayer;   Novartis
    Recruiting - verified November 2009

  • Abatacept Versus Adalimumab Head-to-Head

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: Abatacept;   Drug: Adalimumab
    Sponsor:   Bristol-Myers Squibb
    Recruiting - verified November 2009

  • 1-year Study to Assess the Efficacy, Safety and Tolerability of NVA237 in Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: NVA237;   Drug: Placebo to NVA;   Drug: Tiotropium
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • Long Term Safety Study of Tanezumab in Chronic Low Back Pain

    Condition:   Low Back Pain
    Interventions:   Biological: Tanezumab 20 mg;   Biological: Tanezumab 10 mg
    Sponsor:   Pfizer
    Recruiting - verified November 2009

  • Collecting and Storing Samples From Patients With Lung Cancer

    Condition:   Lung Cancer
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

    Conditions:   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma

    Conditions:   Chordoma;   Desmoid Tumor;   Sarcoma
    Interventions:   Genetic: reverse transcriptase-polymerase chain reaction;   Other: biologic sample preservation procedure;   Other: laboratory biomarker analysis
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors

    Condition:   Brain and Central Nervous System Tumors
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma, Waldenstrom's Macroglobulinemia, Amyloidosis, or Monoclonal Gammopathy of Undetermined Significance

    Conditions:   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Precancerous/Nonmalignant Condition
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)

    Condition:   Benign Prostatic Hyperplasia
    Interventions:   Drug: NX-1207;   Drug: Placebo
    Sponsor:   Nymox Corporation
    Recruiting - verified October 2009

  • Evaluation of Cow Milk-Based Formulas - Functional Proteins

    Condition:   Healthy
    Intervention:  
    Sponsor:   Mead Johnson
    Recruiting - verified October 2009

  • Study Evaluating Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in ErbB-2 Positive Advanced Breast Cancer

    Conditions:   Advanced Breast Cancer;   Breast Cancer
    Interventions:   Drug: Neratinib + Paclitaxel;   Drug: Trastuzumab + Paclitaxel
    Sponsor:   Wyeth
    Recruiting - verified November 2009

  • A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency

    Condition:   Overactive Bladder
    Interventions:   Drug: Fesoterodine;   Drug: Placebo
    Sponsor:   Pfizer
    Recruiting - verified November 2009

  • Study Evaluating the Safety and Efficacy of Bapineuzumab in Subjects With Alzheimer Disease

    Condition:   Alzheimer Disease
    Interventions:   Drug: bapineuzumab;   Drug: placebo
    Sponsor:   Wyeth
    Recruiting - verified November 2009

  • Effect of LY2062430 on the Progression of Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Interventions:   Drug: LY2062430;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

    Condition:   Neuroblastoma
    Interventions:   Genetic: loss of heterozygosity analysis;   Other: cytology specimen collection procedure;   Procedure: biopsy
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

    Condition:   Type 2 Diabetes Mellitus
    Interventions:   Drug: LCQ908A;   Drug: LCQ908A;   Drug: LCQ908A;   Drug: LCQ908A;   Drug: LCQ908A;   Drug: Placebo;   Drug: Sitagliptin
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified October 2009

  • Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy

    Conditions:   Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
    Intervention:   Other: laboratory biomarker analysis
    Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting Tumor Samples From Patients With Gynecological Tumors

    Condition:   Cancer
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

    • Menu
    Find Paid Clinical Trials